Hunterbrook Capital short DexCom, Hunterbrook Media reports

Three people with diabetes died following use of Dexcom’s (DXCM) G7 continuous glucose monitor, according to Hunterbrook Media, citing adverse event reports filed in September with the FDA, and now new reports of deaths have appeared on the FDA’s Manufacturer and User Facility Device Experience, or MAUDE, database, the media organization reports. Based on Hunterbrook Media’s reporting, Hunterbrook Capital is short Dexcom’s shares, the report noted.